ONTX

Onconova Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Onconova Therapeutics Inc ONTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.29% 3.44 14:41:42
Open Price Low Price High Price Close Price Prev Close
3.46 3.37 3.48 3.45
more quote information »

Recent News

Date Time Source Heading
10/01/202111:02EDGARStatement of Ownership (sc 13g)
9/29/202108:28EDGARStatement of Changes in Beneficial Ownership (4)
9/29/202108:26EDGARStatement of Changes in Beneficial Ownership (4)
9/28/202116:05GLOBEOnconova Therapeutics, Inc. Announces Closing of $21 Million..
9/28/202112:34EDGARStatement of Changes in Beneficial Ownership (4)
9/28/202112:33EDGARStatement of Changes in Beneficial Ownership (4)
9/24/202116:19EDGARCurrent Report Filing (8-k)
9/24/202111:08SEEKZIVO Bioscience, Pieris Pharmaceuticals leads healthcare..
9/24/202108:00GLOBEOnconova Therapeutics, Inc. Announces Pricing of $21 Million..
9/23/202116:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/23/202116:01GLOBEOnconova Therapeutics, Inc. Announces Proposed Public..
9/22/202108:06EDGARCurrent Report Filing (8-k)
8/20/202117:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/16/202116:44EDGARQuarterly Report (10-q)
8/05/202106:09EDGARAmended Current Report Filing (8-k/a)
8/04/202119:13EDGARStatement of Changes in Beneficial Ownership (4)
7/30/202119:22EDGARStatement of Changes in Beneficial Ownership (4)
7/30/202119:17EDGARStatement of Changes in Beneficial Ownership (4)
7/30/202119:13EDGARStatement of Changes in Beneficial Ownership (4)
7/30/202119:12EDGARStatement of Changes in Beneficial Ownership (4)
7/30/202117:17EDGARCurrent Report Filing (8-k)
7/16/202117:17EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/16/202117:16EDGARCurrent Report Filing (8-k)
6/28/202108:48SEEKPreliminary early-stage results encouraging for Onconova..
6/25/202117:21EDGARCurrent Report Filing (8-k)
6/22/202108:56SEEKOnconova Therapeutics regains Nasdaq continued listing..
6/22/202108:05EDGARCurrent Report Filing (8-k)
6/17/202119:46EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202119:42EDGARInitial Statement of Beneficial Ownership (3)
5/21/202108:19SEEKOnconova Therapeutics starts dosing in early-stage ON 123300..
5/20/202112:41SEEKOnconova trades lower after announcing reverse stock split
5/20/202108:40EDGARCurrent Report Filing (8-k)
5/18/202108:44SEEKOnconova climbs after Guggenheim initiated coverage with a..
5/17/202117:17EDGARQuarterly Report (10-q)
5/17/202116:23SEEKOnconova shares fall after Q1 results, cash position update
5/17/202116:09SEEKOnconova Therapeutics EPS beats by $0.01, revenue in-line
5/14/202107:32EDGARCurrent Report Filing (8-k)
5/03/202107:31EDGARCurrent Report Filing (8-k)
4/30/202117:02EDGARAmended Annual Report (10-k/a)
4/22/202108:28SEEKOnconova announces dosing of first patient in mid-stage skin..
4/22/202108:00GLOBEOnconova Announces First Patient Dosed in..
4/01/202109:24EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/01/202109:22EDGARCurrent Report Filing (8-k)
4/01/202108:11SEEKEnrollment underway in Onconova's early-stage study of ON..
4/01/202108:00GLOBEOnconova Therapeutics Announces Enrollment in Second Cohort..
3/29/202108:00GLOBEOnconova to Present at the Spring 2021 Oncology Investor..
3/18/202117:30EDGARAnnual Report (10-k)
3/11/202117:26EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/11/202116:34EDGARCurrent Report Filing (8-k)
3/11/202116:19SEEKOnconova Therapeutics EPS in-line, beats on revenue
See more news about this stock »
Your Recent History
NASDAQ
ONTX
Onconova T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211026 18:58:33